Deficiency of C5aR prolongs renal allograft survival

Journal of the American Society of Nephrology

Volumn 21, Issue 8, 2010, Pages 1344-1353

  Li, Qijun ^a   Peng, Qi ^a   Xing, Guolan ^a   Li, Ke ^a   Wang, Naiyin ^a   Farrar, Conrad A ^a   Meader, Lucy ^a   Sacks, Steven H ^a   Zhou, Wuding ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT COMPONENT C5A RECEPTOR DEFICIENCY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DENDRITIC CELL; GRAFT SURVIVAL; IMMUNE RESPONSE; INFLAMMATION; KIDNEY ALLOGRAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 77955615234     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009090977     Document Type: Article

References (41)

1. Walport MJ: Complement. First of two parts. N Engl J Med 344: 1058-1066, 2001
2. Peng Q, Li K, Sacks SH, Zhou W: The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets 8: 236-246, 2009
3. Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Kohl J: The role of the anaphylatoxins in health and disease. Mol Immunol 46: 2753-2766, 2009
4. Guo RF, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821-852, 2005
5. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR, Zetoune FS, Gerard NP, Cianflone K, Kohl J, Gerard C, Sarma JV, Ward PA: Functional roles for C5a receptors in sepsis. Nat Med 14: 551-557, 2008
6. Kohl J, Baelder R, Lewkowich IP, Pandey MK, Hawlisch H, Wang L, Best J, Herman NS, Sproles AA, Zwirner J, Whitsett JA, Gerard C, Sfyroera G, Lambris JD, Wills-Karp M: A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 116: 783-796, 2006
7. Lewis AG, Kohl G, Ma Q, Devarajan P, Kohl J: Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol 153: 117-126, 2008
8. Zheng X, Zhang X, Feng B, Sun H, Suzuki M, Ichim T, Kubo N, Wong A, Min LR, Budohn ME, Garcia B, Jevnikar AM, Min WP: Gene silencing of complement C5a receptor using siRNA for preventing ischemia/ reperfusion injury. Am J Pathol 173: 973-980, 2008
9. Kim AH, Dimitriou ID, Holland MC, Mastellos D, Mueller YM, Altman JD, Lambris JD, Katsikis PD: Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 173: 2524-2529, 2004
10. Fang C, Miwa T, Shen H, Song WC: Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol 179: 3178-3186, 2007
11. Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, Shapiro VS, Dubyak GR, Heeger PS, Medof ME: Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28: 425-435, 2008
12. Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS: Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 112: 1759-1766, 2008
13. Raedler H, Yang M, Lalli PN, Medof ME, Heeger PS: Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant 9: 1784-1795, 2009
14. Peng Q, Li K, Anderson K, Farrar CA, Lu B, Smith RA, Sacks SH, Zhou W: Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 111: 2452-2461, 2008
15. Weinmann O, Gutzmer R, Zwirner J, Wittmann M, Langer K, Lisewski M, Mommert S, Kapp A, Werfel T: Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2. Immunology 110: 458-465, 2003
16. Gutzmer R, Kother B, Zwirner J, Dijkstra D, Purwar R, Wittmann M, Werfel T: Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 126: 2422-2429, 2006
17. Afzali B, Lombardi G, Lechler RI: Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant 13: 438-444, 2008
18. Schena FP: Review of symposium. Sirolimus in kidney transplantation. Transplantation 87: S30-S33, 2009
19. Sehgal SN: Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31: 335-340, 1998
20. Sehgal SN: Sirolimus: Its discovery, biological properties, and mechanism of action. Transplant Proc 35: 7S-14S, 2003
21. LaRosa DF, Rahman AH, Turka LA: The innate immune system in allograft rejection and tolerance. J Immunol 178: 7503-7509, 2007
22. Tan J, Zhou G: Chemokine receptors and transplantation. Cell Mol Immunol 2: 343-349, 2005
23. Gueler F, Rong S, Gwinner W, Mengel M, Brocker V, Schon S, Greten TF, Hawlisch H, Polakowski T, Schnatbaum K, Menne J, Haller H, Shushakova N: Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 19: 2302-2312, 2008
24. Carroll MC: The complement system in regulation of adaptive immunity. Nat Immunol 5: 981-986, 2004
25. Kemper C, Atkinson JP: T-cell regulation: With complements from innate immunity. Nat Rev Immunol 2006
26. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Kohl J: Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 164: 1841-1843, 2001
27. Peng Q, Li K, Wang N, Li Q, Asgari E, Lu B, Woodruff TM, Sacks SH, Zhou W: Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 183: 6058-6068, 2009
28. de VB, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170: 3883-3889, 2003
29. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB J 4: 3355-3359, 1990
30. Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, Fairchild RL: Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 167: 2979-2984, 2001
31. El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL: Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112: 320-331, 2005
32. Hancock WW, Thomson NM, Atkins RC: Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 35: 458-463, 1983
33. Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ: The role of macrophages in allograft rejection. Transplantation 80: 1641-1647, 2005
34. Magil AB: Monocytes/macrophages in renal allograft rejection. Transplant Rev (Orlando) 23: 199-208, 2009
35. Hopken UE, Lu B, Gerard NP, Gerard C: The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86-89, 1996
36. Zhang Z, Schlachta C, Duff J, Stiller C, Grant D, Zhong R: Improved techniques for kidney transplantation in mice. Microsurgery 16: 103-109, 1995
37. Han WR, Murray-Segal LJ, Mottram PL: Modified technique for kidney transplantation in mice. Microsurgery 19: 272-274, 1999
38. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702, 1992
39. Li K, Anderson KJ, Peng Q, Noble A, Lu B, Kelly AP, Wang N, Sacks SH, Zhou W: Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112: 5084-5094, 2008
40. Hus I, Rolinski J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, Giannopoulos K, Dmoszyska A, Schmitt M: Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. Leukemia 19: 1621-1627, 2005
41. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36, 2002